抗癌药物-话题@MedSci

#抗癌药物#

110篇内容 | 3456人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1308206, encodeId=fd751308206fe, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=抗癌药物研发：在失败中涅槃, objectType=article, longId=44577, objectId=d907445e7b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d907445e7b7, replyNumber=0, likeNumber=74, createdTime=2014-12-26, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d907445e7b7, moduleTitle=抗癌药物研发：在失败中涅槃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d907445e7b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308205, encodeId=2017130820525, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=Bind抗癌药物BIND-014二期研究数据喜忧参半, objectType=article, longId=42961, objectId=4338429617e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4338429617e, replyNumber=0, likeNumber=0, createdTime=2014-11-23, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4338429617e, moduleTitle=Bind抗癌药物BIND-014二期研究数据喜忧参半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4338429617e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308204, encodeId=2abe1308204b5, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器, objectType=article, longId=42645, objectId=aaf742645e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaf742645e0, replyNumber=0, likeNumber=70, createdTime=2014-11-19, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaf742645e0, moduleTitle=Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaf742645e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308203, encodeId=d452130820367, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！, objectType=article, longId=41329, objectId=9360413293b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9360413293b, replyNumber=0, likeNumber=105, createdTime=2014-10-18, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9360413293b, moduleTitle=Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9360413293b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308202, encodeId=41eb1308202bb, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=PhRMA：在研771种抗癌药物报告, objectType=article, longId=41238, objectId=432941238d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=432941238d0, replyNumber=0, likeNumber=104, createdTime=2014-10-16, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=432941238d0, moduleTitle=PhRMA：在研771种抗癌药物报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=432941238d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308201, encodeId=890b130820179, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=克雪兰诺、ICR与Wellcome Trust合作开发新型抗癌药物, objectType=article, longId=41018, objectId=30fa41018b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30fa41018b5, replyNumber=0, likeNumber=59, createdTime=2014-10-11, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30fa41018b5, moduleTitle=克雪兰诺、ICR与Wellcome Trust合作开发新型抗癌药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30fa41018b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308200, encodeId=c8d2130820049, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=阿斯利康“死去”的抗癌药物Olaparib“复活”, objectType=article, longId=37141, objectId=ef013e1416c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef013e1416c, replyNumber=0, likeNumber=78, createdTime=2014-06-29, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef013e1416c, moduleTitle=阿斯利康“死去”的抗癌药物Olaparib“复活”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef013e1416c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308199, encodeId=dbd9130819938, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=赛诺菲放弃与Merrimack合作研发抗癌药物, objectType=article, longId=36874, objectId=d24c368e4d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24c368e4d4, replyNumber=0, likeNumber=87, createdTime=2014-06-25, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24c368e4d4, moduleTitle=赛诺菲放弃与Merrimack合作研发抗癌药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24c368e4d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308198, encodeId=531f1308198fa, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=ASCO 2014：新型免疫类抗癌药物NKTR-214临床前研究结果显著, objectType=article, longId=36207, objectId=5ff03620e3d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ff03620e3d, replyNumber=0, likeNumber=67, createdTime=2014-06-11, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ff03620e3d, moduleTitle=ASCO 2014：新型免疫类抗癌药物NKTR-214临床前研究结果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ff03620e3d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308197, encodeId=0736130819e89, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=ASCO 2014：“界定”抗癌药物研发的“临床价值”, objectType=article, longId=35980, objectId=36243598020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36243598020, replyNumber=0, likeNumber=80, createdTime=2014-06-06, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36243598020, moduleTitle=ASCO 2014：“界定”抗癌药物研发的“临床价值”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36243598020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308196, encodeId=ea9e130819605, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=JACC：关注抗癌药物的心脏毒性, objectType=article, longId=32371, objectId=a060323e1fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a060323e1fa, replyNumber=0, likeNumber=78, createdTime=2014-03-27, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a060323e1fa, moduleTitle=JACC：关注抗癌药物的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a060323e1fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308195, encodeId=124f130819558, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=Nat Commun：抗癌药物靶向治疗新技术, objectType=article, longId=31841, objectId=55b33184181, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55b33184181, replyNumber=0, likeNumber=63, createdTime=2014-03-15, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55b33184181, moduleTitle=Nat Commun：抗癌药物靶向治疗新技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55b33184181)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308194, encodeId=c045130819428, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=PNAS：抗癌药物竟会诱发肿瘤, objectType=article, longId=31801, objectId=53fd318011c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53fd318011c, replyNumber=0, likeNumber=70, createdTime=2014-03-14, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53fd318011c, moduleTitle=PNAS：抗癌药物竟会诱发肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53fd318011c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308193, encodeId=34fa1308193ab, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=Science：抗癌药物能治疗免疫缺陷症吗？, objectType=article, longId=27613, objectId=1ffc2e613ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ffc2e613ae, replyNumber=0, likeNumber=77, createdTime=2013-12-07, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ffc2e613ae, moduleTitle=Science：抗癌药物能治疗免疫缺陷症吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ffc2e613ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308192, encodeId=73e41308192f6, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=美国研制出能迫使癌细胞自我毁灭的抗癌药物, objectType=article, longId=26519, objectId=52e526519af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52e526519af, replyNumber=0, likeNumber=87, createdTime=2013-11-14, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52e526519af, moduleTitle=美国研制出能迫使癌细胞自我毁灭的抗癌药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52e526519af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308191, encodeId=70111308191bd, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=PNAS：谁拖了抗癌药物的后腿, objectType=article, longId=20907, objectId=adee2090e8b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adee2090e8b, replyNumber=0, likeNumber=87, createdTime=2013-07-06, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adee2090e8b, moduleTitle=PNAS：谁拖了抗癌药物的后腿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adee2090e8b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308190, encodeId=aa841308190cc, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=NAT COMMUN：对将FAK抑制因子作为抗癌药物开发的再思考, objectType=article, longId=20804, objectId=11ba208045b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11ba208045b, replyNumber=0, likeNumber=67, createdTime=2013-07-04, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11ba208045b, moduleTitle=NAT COMMUN：对将FAK抑制因子作为抗癌药物开发的再思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11ba208045b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308189, encodeId=b030130818927, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=Sci Signal：抗癌药物或可用于治疗肌肉变性疾病, objectType=article, longId=18146, objectId=0eb318146dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0eb318146dc, replyNumber=0, likeNumber=70, createdTime=2013-05-08, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0eb318146dc, moduleTitle=Sci Signal：抗癌药物或可用于治疗肌肉变性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eb318146dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308188, encodeId=747b1308188c6, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=Genet in Med：抗癌药物或可助力庞贝氏症患者的治疗, objectType=article, longId=18125, objectId=03c41812565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03c41812565, replyNumber=0, likeNumber=57, createdTime=2013-05-08, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03c41812565, moduleTitle=Genet in Med：抗癌药物或可助力庞贝氏症患者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03c41812565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1308187, encodeId=9f7b130818e53, content=<a href='/topic/show?id=6e495554550' target=_blank style='color:#2F92EE;'>#抗癌药物#</a>, objectTitle=JMC：碳硼烷可明显增加抗癌药物药效, objectType=article, longId=9649, objectId=17b896498d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17b896498d, replyNumber=0, likeNumber=62, createdTime=2012-09-12, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17b896498d, moduleTitle=JMC：碳硼烷可明显增加抗癌药物药效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17b896498d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗癌药物

2020-05-29

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

抗癌药物研发：在失败中涅槃

2014-12-26

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

Bind抗癌药物BIND-014二期研究数据喜忧参半

2014-11-23

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器

2014-11-19

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！

2014-10-18

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

PhRMA：在研771种抗癌药物报告

2014-10-16

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

克雪兰诺、ICR与Wellcome Trust合作开发新型抗癌药物

2014-10-11

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

阿斯利康“死去”的抗癌药物Olaparib“复活”

2014-06-29

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

赛诺菲放弃与Merrimack合作研发抗癌药物

2014-06-25

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

ASCO 2014：新型免疫类抗癌药物NKTR-214临床前研究结果显著

2014-06-11

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

ASCO 2014：“界定”抗癌药物研发的“临床价值”

2014-06-06

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

JACC：关注抗癌药物的心脏毒性

2014-03-27

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

Nat Commun：抗癌药物靶向治疗新技术

2014-03-15

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

PNAS：抗癌药物竟会诱发肿瘤

2014-03-14

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

Science：抗癌药物能治疗免疫缺陷症吗？

2013-12-07

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

美国研制出能迫使癌细胞自我毁灭的抗癌药物

2013-11-14

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

PNAS：谁拖了抗癌药物的后腿

2013-07-06

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

NAT COMMUN：对将FAK抑制因子作为抗癌药物开发的再思考

2013-07-04

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

Sci Signal：抗癌药物或可用于治疗肌肉变性疾病

2013-05-08

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

Genet in Med：抗癌药物或可助力庞贝氏症患者的治疗

2013-05-08

flyingeagle77 (审核中...)

前往app查看评论内容

#抗癌药物#

JMC：碳硼烷可明显增加抗癌药物药效

2012-09-12

科室
- - 订阅+
  - 更多科室
工具
服务